Fieldpoint Private Securities’s Biogen BIIB Stock Holding History

Fieldpoint Private Securities’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	1295
2022 Q1	$1K	Sell	5 -35	-88%	-$7.61K	﹤0.01%	1543
2021 Q4	$10K	Sell	40 -15	-27%	-$3.86K	﹤0.01%	1073
2021 Q3	$16K	Hold	55	–	–	﹤0.01%	869
2021 Q2	$19K	Hold	55	–	–	﹤0.01%	816
2021 Q1	$15K	Buy	55 +10	+22%	+$2.7K	﹤0.01%	871
2020 Q4	$11K	Sell	45 -1,134	-96%	-$293K	﹤0.01%	866
2020 Q3	$334K	Buy	1,179 +302	+34%	+$84.2K	0.1%	215
2020 Q2	$235K	Buy	+877	New	+$264K	0.08%	220
2019 Q4	–	Sell	-56	Closed	-$13K	–	646
2019 Q3	$13K	Buy	56 +7	+14%	+$1.63K	﹤0.01%	551
2019 Q2	$11K	Buy	+49	New	+$11.3K	﹤0.01%	616
2018 Q2	–	Sell	-114	Closed	-$31K	–	405
2018 Q1	$31K	Buy	114 +99	+660%	+$30.7K	0.01%	322
2017 Q4	$5K	Sell	15 -89	-86%	-$28.6K	﹤0.01%	366
2017 Q3	$33K	Buy	104 +89	+593%	+$26.4K	0.01%	437
2017 Q2	$4K	Hold	15	–	–	﹤0.01%	149
2017 Q1	$4K	Buy	+15	New	+$4.24K	﹤0.01%	331

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fieldpoint Private Securities's BIIB Position: Q2 2022 in Review

Fieldpoint Private Securities held its Biogen (BIIB) position steady in Q2 2022 at 5 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.

Fieldpoint Private Securities first reported a position in BIIB in Q1 2017 and has held it in 16 quarters since. The position peaked at $334K in Q3 2020. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

Fieldpoint Private Securities held 5 shares of Biogen worth $1K as of Q2 2022.
Fieldpoint Private Securities left its Biogen share count unchanged in Q2 2022.
Biogen made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1295 holding.
Fieldpoint Private Securities first reported a position in Biogen in Q1 2017 and has held it in 16 quarters since.
Fieldpoint Private Securities's Biogen position peaked at $334K in Q3 2020.
928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.